U.S., Dec. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07270601) titled 'Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis' on Nov. 19.
Brief Summary: The research study is considering a non-invasive way to measure the percentage of fat in the liver using ultrasound. This could help detect early signs of a very common condition called metabolic dysfunction-associated steatotic liver disease (MASLD). Current tests, like MRI or biopsy, can be expensive or invasive. If successful, this ultrasound tool could become an easier and more accessible way to monitor liver health - especially for people with obesity, diabetes, high blood pressure, or high cholesterol.
Study Start Date: Nov. 17...